Wiesmann; Marion

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wiesmann; Marion.The latest application filed is for "combination therapies".

Company Profile

1.11.14

Wiesmann; Marion - Basel CH
Wiesmann; Marion - Bottmingen N/A CH
Wiesmann; Marion - Emeryville CA
Wiesmann; Marion - Brisbane CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapies App 20200277378 - Sabatos-Peyton; Catherine Anne ; et al.	2020-09-03
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 8,710,048 - Sutton , et al. April 29, 2	2014-04-29
Pyrimidine derivatives used as PI-3 kinase inhibitors Grant 8,563,549 - Burger , et al. October 22, 2	2013-10-22
Methods for treating drug resistant cancer Grant 8,299,081 - Michelson , et al. October 30, 2	2012-10-30
CSF-1R inhibitors, compositions, and methods of use Grant 8,293,769 - Ng , et al. October 23, 2	2012-10-23
6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling App 20120225861 - Sutton; James C. ; et al.	2012-09-06
Pyrimidine Derivatives Used As Pi-3 Kinase Inhibitors App 20120225859 - BURGER; Matthew ; et al.	2012-09-06
Pyrimidine derivatives used as PI-3-kinase inhibitors Grant 8,217,035 - Burger , et al. July 10, 2	2012-07-10
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 8,173,689 - Sutton , et al. May 8, 2	2012-05-08
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling App 20100280006 - Sutton; James C. ; et al.	2010-11-04
Inhibition of FGFR3 and treatment of multiple myeloma Grant 7,825,132 - Cai , et al. November 2, 2	2010-11-02
Pyrimidine Derivatives Used As Pi-3-kinase Inhibitors App 20100249126 - Burger; Matthew ; et al.	2010-09-30
Csf-1r Inhibitors,compositions, And Methods Of Use App 20100130490 - Ng; Simon C. ; et al.	2010-05-27
Treatment Of Melanoma App 20100086518 - Heise; Carla C. ; et al.	2010-04-08
Pi3 Kinase Inhibitors And Methods Of Their Use App 20100075965 - Ni; Zhi-Jie ; et al.	2010-03-25
Benzimidazole quinolinones and uses thereof App 20090281100 - Barsanti; Paul A. ; et al.	2009-11-12
Methods for treating drug resistant cancer App 20090215793 - Michelson; Glenn C. ; et al.	2009-08-27
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 7,553,854 - Sutton , et al. June 30, 2	2009-06-30
Benzimidazole quinolinones and uses thereof Grant 7,470,709 - Barsanti , et al. December 30, 2	2008-12-30
6-o-substituted Benzoxazole And Benzothiazole Compounds And Methods Of Inhibiting Csf-1r Signaling App 20080045528 - Sutton; JamesC ; et al.	2008-02-21
Inhibition of FGFR3 and treatment of multiple myeloma App 20050261307 - Cai, Shaopei ; et al.	2005-11-24
Benzimidazole quinolinones and uses thereof App 20050203101 - Barsanti, Paul A. ; et al.	2005-09-15
Benzimidazole quinolinones and uses thereof App 20040092535 - Barsanti, Paul A. ; et al.	2004-05-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.